HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Energy drink innovation declines

This article was originally published in The Tan Sheet

Executive Summary

Market research firm Mintel reports that, after a surge of nearly 400 energy drink and energy shot product introductions in 2008, the rate of launches slowed dramatically, with only 46 new products introduced from January to May 2009. However, sales in the energy beverage segment grew approximately 240 percent between 2004 and 2009, according to the firm's July report on energy beverages. While Mintel projects 2009 energy drink sales will reach $4.6 billion, the recession slowed market growth to less than 10 percent from 2007 to 2008. The firm previously predicted growth would slow as shelves become saturated with energy products (1"The Tan Sheet" Sept. 8, 2008)

You may also be interested in...



Market Experts See Energy Drink Growth Flagging, Dominant Players Reigning

Beverage industry experts foresee the explosive growth rate of the energy drink market falling to earth during the next five years, as products have virtually saturated the market and new customer segments have failed to materialize

At Muted J.P. Morgan, Focus Is Execution, But US Pricing Is Persistent Overhang

Political worries aside, industry is confidently executing on focused strategies as it welcomes a new decade, even if a lack of deal news at the J.P. Morgan Healthcare Conference didn't excite investors.

FDA Action Items For CBD Policy? The List Is Short Due To 'Critical' Data Gaps

FDA has little in the way of good information it can list on its CBD policy agenda so far, says Principal Deputy Commissioner Amy Abernethy. At recent regulatory conference, she said, "Like it or not, there is a massive human experiment going on right now. There’s CBD in most different product categories and people of many different backgrounds with potential vulnerabilities taking CBD."

Topics

UsernamePublicRestriction

Register

RS136185

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel